HeartLung

Company profile

About HeartLung

HeartLung Corporation is a medical imaging AI company focused on preventing deaths from cardiovascular disease and lung cancer through early detection. The company's flagship AI-CVD platform automatically analyzes routine CT scans—including cardiac, pulmonary, oncology, emergency, and preventive imaging—to extract quantitative imaging biomarkers that often go unmeasured or underreported. The platform generates physician-facing reports covering cardiovascular health, cardiometabolic health, lung health, and bone health from a single non-contrast scan. HeartLung's suite includes AI-CAC for coronary artery calcium scoring, AutoBMD for bone mineral density assessment, AutoChamber for cardiac chamber volume analysis, and modules for liver fat, emphysema, aortic measurements, and muscle/visceral fat quantification. The technology is designed to help imaging centers, radiology groups, cardiology practices, and health systems create new clinical value from existing scan volume while identifying patients who may benefit from earlier follow-up care. Founded by Dr. Morteza Naghavi, a physician researcher and entrepreneur in preventive cardiology, HeartLung is backed by world-renowned researchers and pioneers in cardiovascular imaging including Dr. Arthur Agatston (inventor of the Agatston Calcium Score), Dr. Claudia Henschke and Dr. David Yankelevitz (pioneers in lung cancer screening), and Dr. Anthony Reeves (Cornell professor and leader in automated lung and cardiac CT). The company holds multiple US patents and operates from Houston, Texas.

Company description · HeartLung official website